Capital City Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Capital City Trust's PFE Position: Q3 2023 in Review
Capital City Trust sold out of Pfizer (PFE) in Q3 2023, closing a stake of 8,163 shares — an estimated $299K sold.
Capital City Trust first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $484K in Q2 2022. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Capital City Trust reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Capital City Trust sold 8,163 Pfizer shares in Q3 2023, an estimated $299K.
- Capital City Trust first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
- Capital City Trust's Pfizer position peaked at $484K in Q2 2022.
- 2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Capital City Trust's 13F filing for Q3 2023, filed 12 Oct 2023.